의료 대책 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2023-2030년) - 제품별, 용도별, 지역별(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카)

Medical Countermeasures Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

US $ 4,995 ￦ 6,853,000

Unprintable PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.

US $ 8,495 ￦ 11,655,000

Unprintable PDF & Excel (Multi User License upto 5 users)

PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.

US $ 10,600 ￦ 14,544,000

Printable PDF & Excel (Enterprise License above 5 users)

PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 의료 대책 시장 규모는 불확실한 발생에 대처하기 위해 입수하기 쉽고 효과적인 의약품에 대한 수요의 증가에 의해 지원되며 헬스케어 산업에서 큰 약진을 달성하고 있습니다. 헬스케어 종사자의 노력을 유지하고, 질병의 만연을 방지하기 위한 강고하고 적절한 의료 대책이 필요하게 되는 가운데 시장은 의약품의 안전성 보증에서 현저한 성장을 향해 전진하고 있습니다.

세계의 의료 대책 시장에 대해 조사했으며, 시장의 개요와 유형별, 제품별, 용도별, 지역별 동향 및 시장에 참여하는 기업의 경쟁 동향 등을 제공하고 있습니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장의 정의와 세분화
• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
• 규제 프레임워크
• 정부 구상과 투자
• 기술의 진보
• PESTLE 분석
• 밸류체인 분석
• COVID-19의 영향 분석

제3장 세계의 의료 대책 시장 전망, 2018-2030년

• 세계의 의료 대책 시장 전망, 유형별, 2018-2030년
• 세계의 의료 대책 시장 전망, 제품별, 2018-2030년
• 세계의 의료 대책 시장 전망, 용도별, 2018-2030년
• 세계의 의료 대책 시장 전망, 지역별, 2018-2030년

제4장 북미의 의료 대책 시장 전망, 2018-2030년

제5장 유럽의 의료 대책 시장 전망, 2018-2030년

제6장 아시아태평양의 의료 대책 시장 전망, 2018-2030년

제7장 라틴아메리카의 의료 대책 시장 전망, 2018-2030년

제8장 중동 및 아프리카의 의료 대책 시장 전망, 2018-2030년

제9장 경쟁 구도

• 시장 점유율 분석
• 기업 개요
  • Pfizer, Inc.
  • Altimmune, Inc.
  • SIGA Technologies
  • Bavarian Nordic A/S
  • Dynavax Technologies Corporation
  • National Resilience, Inc.
  • GSK plc
  • Xoma Corporation
  • Meridian Medical Technologies, LLC
  • Bruker Detection
  • Ichor Medical Systems
  • Teledyne Technologies, Inc.
  • 기타

제10장 부록

KSA

영문 목차

영문목차

The global medical countermeasures market is experiencing a major breakthrough in the healthcare industry, driven by the increasing demand for accessible and effective medicines to combat uncertain outbreaks. With the need for robust and apt medical countermeasures to sustain the efforts of healthcare workers and prevent the spread of diseases, the market is advancing towards significant growth in the safety assurance of drugs.

Growing Demand for Medical Countermeasures in the Face of Uncertain Outbreaks

Healthcare providers are increasingly relying on medical countermeasures to address the uncertainty of outbreaks and ensure accessible medicines with fewer side effects upon successful diagnosis. The availability of extensive vaccines or antivirals that are unapproved can lead to ineffective treatments, undermining efforts to produce safe and effective drugs. To maintain consistent efforts in healthcare and prevent diseases from spreading, the demand for robust and suitable medical countermeasures has risen incessantly.

Rigorous Quality Checks and Clinical Trials Enhance Market Potential

Before entering the market, drugs undergo rigorous quality checks and clinical trials to ensure their safety and efficacy. Government agencies like the U.S. Food and Drug Administration (FDA) pre-evaluate medications sold in the market, further assuring safety to consumers. These stringent quality checks, coupled with growing awareness of medical countermeasures and unpredictable outbreaks, are expected to expand the dimensions of the medical countermeasures market and boost sales in the coming years.

Rising Prevalence of Infectious Diseases and Advancements in Precision Medicines Propel Market Growth

The medical countermeasures market, comprising medical devices and therapeutic products, is dominated by vaccines, particularly due to the prevalence of infectious diseases like HIV/AIDS. The market is witnessing continuous growth as an increasing number of patients require life-saving vaccines to combat lethal diseases such as dengue and influenza virus (H1N1). Advancements in personalized medicine and Matrix Metalloproteinases (MMPs) are also expected to drive market expansion. Additionally, rising awareness about countermeasures to combat biological agents further boosts the momentum for the medical countermeasures market.

Asia Pacific Emerges as a Promising Market with Robust Investments in Research & Development

While the U.S. leads the global medical countermeasures market with strict norms and regulations on drug development and rising awareness about bioterrorism attacks, Asia Pacific is poised to demonstrate substantial growth during the forecast period. The region's market is influenced by increasing biological warfare threats and growing investments in research and development by key players to develop countermeasures against bio aggressors. Moreover, the region's sophisticated infrastructure and government investments in the latest countermeasures and R&D contribute to market growth.

Leading Players Shaping the Global Medical Countermeasures Market

Some of the prominent players operating in the global medical countermeasures market include: Sanofi Pasteur, Johnson & Johnson, CSL Limited, GlaxoSmithKline plc, Pfizer, Inc., Emergent BioSolutions, Inc., Daiichi Sankyo Company, Limited, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd., Merck & Co., Inc., Bavarian Nordic, AstraZeneca, Bharat Biotech, Incepta Vaccine Ltd., Biological E, Sinovac Biotech Ltd., Valneva SE, PT Bio Farma, Panacea Biotec, and VBI Vaccines Inc.

Table of Contents

1. Executive Summary

• 1.1. Global Medical Countermeasures Market Outlook, 2018 - 2030 (US$ Million)
• 1.2. Global Medical Countermeasures Market Incremental Opportunity, 2018 - 2030 (US$ Million)
• 1.3. Key Industry Trends

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
    • 2.2.1.1. Driver 1
    • 2.2.1.2. Driver 2
  • 2.2.2. Restraints
    • 2.2.2.1. Restraint 1
    • 2.2.2.2. Restraint 2
  • 2.2.3. Opportunities
    • 2.2.3.1. Opportunity 1
    • 2.2.3.2. Opportunity 2
• 2.3. Regulatory Framework
• 2.4. Government Initiatives and Investments
• 2.5. Technological Advancements
• 2.6. PESTLE Analysis
• 2.7. Value Chain Analysis
• 2.8. COVID-19 Impact Analysis

3. Global Medical Countermeasures Market Outlook, 2018 - 2030

• 3.1. Global Medical Countermeasures Market Outlook, by Type, 2018 - 2030
  • 3.1.1. Key Highlights
  • 3.1.2. Global Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
    • 3.1.2.1. Drugs
    • 3.1.2.2. Biologics
    • 3.1.2.3. Devices
  • 3.1.3. Global Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
  • 3.1.4. Global Medical Countermeasures Market Attractiveness Analysis, by Type, 2023 - 2030
• 3.2. Global Medical Countermeasures Market Outlook, By Product, 2018 - 2030
  • 3.2.1. Key Highlights
  • 3.2.2. Global Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
    • 3.2.2.1. Diagnostic
    • 3.2.2.2. Therapeutic
    • 3.2.2.3. Prophylactic
  • 3.2.3. Global Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
  • 3.2.4. Global Medical Countermeasures Market Attractiveness Analysis, By Product, 2023 - 2030
• 3.3. Global Medical Countermeasures Market Outlook, By Application, 2018 - 2030
  • 3.3.1. Key Highlights
  • 3.3.2. Global Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
    • 3.3.2.1. Small pox
    • 3.3.2.2. Anthrax
    • 3.3.2.3. Botulism
    • 3.3.2.4. Chemical Threat
    • 3.3.2.5. Radiological/Nuclear Threat
    • 3.3.2.6. Emerging Infectious Diseases
    • 3.3.2.7. Others
  • 3.3.3. Global Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
  • 3.3.4. Global Medical Countermeasures Market Attractiveness Analysis, by Application, 2023 - 2030
• 3.4. Global Medical Countermeasures Market Outlook, By Region, 2018 - 2030
  • 3.4.1. Key Highlights
  • 3.4.2. Global Medical Countermeasures Market Outlook, by Region, Value (US$ Million), 2018 - 2030
    • 3.4.2.1. North America
    • 3.4.2.2. Europe
    • 3.4.2.3. Asia Pacific
    • 3.4.2.4. Latin America
    • 3.4.2.5. Middle East & Africa
  • 3.4.3. Global Medical Countermeasures Market Share and BPS Analysis, by Region, 2023 and 2030
  • 3.4.4. Global Medical Countermeasures Market Attractiveness Analysis, by Region, 2023 - 2030

4. North America Medical Countermeasures Market Outlook, 2018 - 2030

• 4.1. North America Medical Countermeasures Market Outlook, by Type, 2018 - 2030
  • 4.1.1. Key Highlights
  • 4.1.2. North America Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
    • 4.1.2.1. Drugs
    • 4.1.2.2. Biologics
    • 4.1.2.3. Devices
  • 4.1.3. North America Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
• 4.2. North America Medical Countermeasures Market Outlook, By Product, 2018 - 2030
  • 4.2.1. Key Highlights
  • 4.2.2. North America Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
    • 4.2.2.1. Diagnostic
    • 4.2.2.2. Therapeutic
    • 4.2.2.3. Prophylactic
  • 4.2.3. North America Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
• 4.3. North America Medical Countermeasures Market Outlook, By Application, 2018 - 2030
  • 4.3.1. Key Highlights
  • 4.3.2. North America Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
    • 4.3.2.1. Small pox
    • 4.3.2.2. Anthrax
    • 4.3.2.3. Botulism
    • 4.3.2.4. Chemical Threat
    • 4.3.2.5. Radiological/ Nuclear Threat
    • 4.3.2.6. Emerging Infectious Diseases
    • 4.3.2.7. Others
  • 4.3.3. North America Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
• 4.4. North America Medical Countermeasures Market Outlook, By Country, 2018 - 2030
  • 4.4.1. Key Highlights
  • 4.4.2. North America Market Outlook, by Country, Value (US$ Million), 2018 - 2030
    • 4.4.2.1. U.S.
    • 4.4.2.2. Canada
  • 4.4.3. North America Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

5. Europe Medical Countermeasures Market Outlook, 2018 - 2030

• 5.1. Europe Medical Countermeasures Market Outlook, by Type, 2018 - 2030
  • 5.1.1. Key Highlights
  • 5.1.2. Europe Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
    • 5.1.2.1. Drugs
    • 5.1.2.2. Biologics
    • 5.1.2.3. Devices
  • 5.1.3. Europe Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
• 5.2. Europe Medical Countermeasures Market Outlook, By Product, 2018 - 2030
  • 5.2.1. Key Highlights
  • 5.2.2. Europe Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
    • 5.2.2.1. Diagnostic
    • 5.2.2.2. Therapeutic
    • 5.2.2.3. Prophylactic
  • 5.3.3. Europe Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
• 5.3. Europe Medical Countermeasures Market Outlook, By Application, 2018 - 2030
  • 5.3.1. Key Highlights
  • 5.3.2. Europe Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
    • 5.3.2.1. Small pox
    • 5.3.2.2. Anthrax
    • 5.3.2.3. Botulism
    • 5.3.2.4. Chemical Threat
    • 5.3.2.5. Radiological/Nuclear Threat
    • 5.3.2.6. Emerging Infectious Diseases
    • 5.3.2.7. Others
  • 5.3.3. Europe Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
• 5.4. Europe Medical Countermeasures Market Outlook, By Country, 2018 - 2030
  • 5.4.1. Key Highlights
  • 5.4.2. Europe Medical Countermeasures Market Outlook, by Country, Value (US$ Million), 2018 - 2030
    • 5.4.2.1. Germany
    • 5.4.2.2. France
    • 5.4.2.3. U.K.
    • 5.4.2.4. Italy
    • 5.4.2.5. Spain
    • 5.4.2.6. Russia
    • 5.4.2.7. Rest of Europe
  • 5.4.3. Europe Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

6. Asia Pacific Medical Countermeasures Market Outlook, 2018 - 2030

• 6.1. Asia Pacific Medical Countermeasures Market Outlook, by Type, 2018 - 2030
  • 6.1.1. Key Highlights
  • 6.1.2. Asia Pacific Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
    • 6.1.2.1. Drugs
    • 6.1.2.2. Biologics
    • 6.1.2.3. Devices
  • 6.1.3. Asia Pacific Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
• 6.2. Asia Pacific Medical Countermeasures Market Outlook, By Product, 2018 - 2030
  • 6.2.1. Key Highlights
  • 6.2.2. Asia Pacific Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
    • 6.2.2.1. Diagnostic
    • 6.2.2.2. Therapeutic
    • 6.2.2.3. Prophylactic
  • 6.2.3. Asia Pacific Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
• 6.3. Asia Pacific Medical Countermeasures Market Outlook, By Application, 2018 - 2030
  • 6.3.1. Key Highlights
  • 6.3.2. Asia Pacific Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
    • 6.3.2.1. Small pox
    • 6.3.2.2. Anthrax
    • 6.3.2.3. Botulism
    • 6.3.2.4. Chemical Threat
    • 6.3.2.5. Radiological/Nuclear Threat
    • 6.3.2.6. Emerging Infectious Diseases
    • 6.3.2.7. Others
  • 6.3.3. Asia Pacific Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
• 6.4. Asia Pacific Medical Countermeasures Market Outlook, By Country, 2018 - 2030
  • 6.4.1. Key Highlights
  • 6.4.2. Asia Pacific Medical Countermeasures Market Outlook, by Country, Value (US$ Million), 2018 - 2030
    • 6.4.2.1. Japan
    • 6.4.2.2. China
    • 6.4.2.3. India
    • 6.4.2.4. Australia & New Zealand
    • 6.4.2.5. South Korea
    • 6.4.2.6. Rest of Asia Pacific
  • 6.4.3. Asia Pacific Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

7. Latin America Medical Countermeasures Market Outlook, 2018 - 2030

• 7.1. Latin America Medical Countermeasures Market Outlook, by Type, 2018 - 2030
  • 7.1.1. Key Highlights
  • 7.1.2. Latin America Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
    • 7.1.2.1. Drugs
    • 7.1.2.2. Biologics
    • 7.1.2.3. Devices
  • 7.1.3. Latin America Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
• 7.2. Latin America Medical Countermeasures Market Outlook, By Product, 2018 - 2030
  • 7.2.1. Key Highlights
  • 7.2.2. Latin America Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
    • 7.2.2.1. Diagnostic
    • 7.2.2.2. Therapeutic
    • 7.2.2.3. Prophylactic
  • 7.2.3. Latin America Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
• 7.3. Latin America Medical Countermeasures Market Outlook, By Application, 2018 - 2030
  • 7.3.1. Key Highlights
  • 7.3.2. Latin America Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
    • 7.3.2.1. Small pox
    • 7.3.2.2. Anthrax
    • 7.3.2.3. Botulism
    • 7.3.2.4. Chemical Threat
    • 7.3.2.5. Radiological/Nuclear Threat
    • 7.3.2.6. Emerging Infectious Diseases
    • 7.3.2.7. Others
  • 7.3.3. Latin America Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
• 7.4. Latin America Medical Countermeasures Market Outlook, By Country, 2018 - 2030
  • 7.4.1. Key Highlights
  • 7.4.2. Latin America Medical Countermeasures Market Outlook, by Country, Value (US$ Million), 2018 - 2030
    • 7.4.2.1. Brazil
    • 7.4.2.2. Mexico
    • 7.4.2.3. Argentina
    • 7.4.2.4. Rest of Latin America
  • 7.4.3. Latin America Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

8. Middle East & Africa Medical Countermeasures Market Outlook, 2018 - 2030

• 8.1. Middle East & Africa Medical Countermeasures Market Outlook, Type, 2018 - 2030
  • 8.1.1. Key Highlights
  • 8.1.2. Middle East & Africa Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
    • 8.1.2.1. Drugs
    • 8.1.2.2. Biologics
    • 8.1.2.3. Devices
  • 8.1.3. Middle East & Africa Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
• 8.2. Middle East & Africa Medical Countermeasures Market Outlook, By Product, 2018 - 2030
  • 8.2.1. Key Highlights
  • 8.2.2. Middle East & Africa Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
    • 8.2.2.1. Diagnostic
    • 8.2.2.2. Therapeutic
    • 8.2.2.3. Prophylactic
  • 8.2.3. Middle East & Africa Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
• 8.3. Middle East & Africa Medical Countermeasures Market Outlook, By Application, 2018 - 2030
  • 8.3.1. Key Highlights
  • 8.3.2. Middle East & Africa Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
    • 8.3.2.1. Small pox
    • 8.3.2.2. Anthrax
    • 8.3.2.3. Botulism
    • 8.3.2.4. Chemical Threat
    • 8.3.2.5. Radiological/Nuclear Threat
    • 8.3.2.6. Emerging Infectious Diseases
    • 8.3.2.7. Others
  • 8.3.3. Middle East & Africa Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
• 8.4. Middle East & Africa Medical Countermeasures Market Outlook, By Country, 2018 - 2030
  • 8.4.1. Key Highlights
  • 8.4.2. Middle East & Africa Medical Countermeasures Market Outlook, by Country, Value (US$ Million), 2018 - 2030
    • 8.4.2.1. Saudi Arabia
    • 8.4.2.2. UAE
    • 8.4.2.3. South Africa
    • 8.4.2.4. Rest of Middle East & Africa
  • 8.4.3. Middle East & Africa Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

9. Competitive Landscape

• 9.1. Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1. Pfizer, Inc.
    • 9.2.1.1. Company overview
    • 9.2.1.2. Financial performance
    • 9.2.1.3. Product Portfolio
    • 9.2.1.4. Recent Developments
  • 9.2.2. Altimmune, Inc.
  • 9.2.3. SIGA Technologies
  • 9.2.4. Bavarian Nordic A/S
  • 9.2.5. Dynavax Technologies Corporation
  • 9.2.6. National Resilience, Inc.
  • 9.2.7. GSK plc
  • 9.2.8. Xoma Corporation
  • 9.2.9. Meridian Medical Technologies, LLC
  • 9.2.10. Bruker Detection
  • 9.2.11. Ichor Medical Systems
  • 9.2.12. Teledyne Technologies, Inc.
  • 9.2.13. Others

10. Appendix

• 10.1. Research Methodology
• 10.2. Report Specific Research Approach
• 10.3. Acronyms and Abbreviations

관련자료